Alanine transaminase level in a healthy population in Morocco

Pakistan Journal of Biological Sciences

Volumn 15, Issue 5, 2012, Pages 238-243

  Laouina, A ^a,b   Abouyoub, A ^a   Soulaymani, A ^b   Alami, Raouf ^a  

^a IBN SINA HOSPITAL   (Morocco)

^b IBN TOFAIL UNIVERSITY   (Morocco)

Author keywords

Alanine trmaminase; Blood donors; Etiology; Morocco; Upper limit of normal ALT (ULN)

Indexed keywords

HEPATITIS C VIRUS;

EID: 84863703198     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2012.238.243     Document Type: Article

References (45)

1. Allard, P.R. and R. Parent, 2008. Risk Factors for Hepatitis C: Analysis of Epidemiological Studies Done in Quebec. National Public Health Institute of Quebec, Quebec, Canada.
2. Assal, H.S., M. Fath-Allah and A. Elsherbiny, 2007. Serum leptin and adiponectin in obese diabetic and non-diabetic. J. Med. Sci., 7: 865-869.
3. Blajchman, M.A., S.B. Bull and S.V. Feinman, 1995. Post-transfusion hepatitis: Impact of non-A, non-B hepatitis surrogate tests. Lancet, 345: 21-25.
4. Brinkmann, T., J. Dreier, J. Diekmann, C. Gotting, R. Klauke, G. Schumann and K. Kleesiek, 2003. Alanine aminotransferase cut-off values for blood donor screening using the new International Federation of Clinical Chemistry reference method at 37°C. Vox Sanguinis, 85: 159-164.
5. Ciangura, C., 2010. From obesity to obese patient. Pelvic Perineol., 5: 33-38.
6. Desforges, J.F., F. Athari, E.S. Cooper, C.S. Johnson and S.M. Lemon et al., 1995. Infectious disease testing for blood transfusions. J. Am. Med. Assoc., 274: 1374-1379.
7. Dieusaert, P., 1999. Transaminase (TGO or AST, TGP or ALT): Practical Guide for Medical Tests. 2nd Edn., Maloine Publisher, Paris, pp: 1071-1074.
8. Ebuehi, O.A.T. and C.L. Asonye, 2007. Gender and alcohol consumption affect human serum enzymes, protein and bilirubin. Asian J. Biochem., 2: 330-336.
9. Ghaffour, M., 2009. Prevalence of viral hepatitis B and C among blood donors in CHUT 1996-2007. Proceedings of the 8th Medico-Surgical Interviews, (MSI'09), Tlemcen, Algeria-.
10. Ito, H., K. Yoshioka, K. Ukai, K. Watanabe and M. Yano et al., 2004. The fluctuations of viral load and serum alanine aminotransferase levels in chronic hepatitis C. Hepatol. Res., 30: 11-17.
11. Jain, S. and N. Kaplowitz, 2010. Clinical Considerations of Drug-Induced Hepatotoxicity. In: Comprehensive Toxicology, McQueen, C.A. (Ed.). 2nd Edn. Elsevier Science and Technology, New York, USA., ISBN-13: 9780080468686, pp: 369-381.
12. Jamali, R., A. Pourshams, S. Amini, M.R. Deyhim, H. Rezvan and R. Malekzadeh, 2008. The upper normal limit of serum alanine aminotransferase in Golestan Province, Northeast Iran. Arch. Iran. Med., 11: 602-607.
13. Jamali, R., M. Khonsari, S. Merat, M. Khoshnia and E. Jafari et al., 2008. Persistent alanine aminotransferase elevation among the general Iranian population: Prevalence and causes. World J. Gastroenterol., 14: 2867-2871.
14. Kaplan, M.M., 2002. Alanine aminotransferase levels: What's normal? Ann. Med. Int., 137: 49-51.
15. Kechagias, S., A. Ernersson, O. Dahlqvist, P. Lundberg, T. Lindstrom and F.H. Nystrom, 2008. Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut, 57: 649-654.
16. Khammassi, N., J. Chrifi, M. Dorsaf, A. Haykel, M.N. Tougourti, Z. Hassen and M. Hamza, 2009. Fatale post transfusionnel hepatitis CMV of fatal outcome. Tunisie Med., 87: 356-358.
17. Kobayashi, Y., Y. Kawaguchi, T. Mizuta, T. Kuwashiro and S. Oeda et al., 2011. Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C. J. Gastroenterol., 46: 529-535.
18. Konca, Y., F. Kirkpinar, S. Mert and S. Yurtseven, 2009. Effects of dietary ascorbic acid supplementation on growth performance, carcass, bone quality and blood parameters in broilers during natural summer temperature. Asian J. Anim. Vet. Adv., 4: 139-147.
19. Kumar, S.R., N.K. Sana, A. Rauf and M. Uddin, 2004. Studies on the liver function tests (LFTs) of obstructive jaundice, acute and chronic hepatitis patients. Pak. J. Biol. Sci., 7: 109-113.
20. Liu, C., T.H. Tung, J.H. Liu, V.T. Chen, C.H. Lin, C.T. Hsu and P. Chou, 2005. A community-based epidemiological study of elevated serum alanine aminotransferase levels in Kinmen, Taiwan. World J. Gastroenterol., 11: 1616-1622.
21. Mastouri, M., I.L. Safer, B. Pozzetto, T. Bourlet and M. Khedher, 2005. Prevalence of hepatitis G virus among Tunisian blood donors. Eastern Mediterranean Health J., 11: 1053-1060.
22. Megarbane, B., N. Deye and F. Baud, 2007. Toxic hepatitis: Mechanisms of toxicity and specific pharmacological agents. Reanimation, 16: 632-642.
23. Mele, A., T. Stroffolini, R. Catapano, F. Palumbo, A. Moiraghi and F. Novaco, 1995. Incidence of transfusion associated B and non-A, non-B hepatitis in Italy. Br. Med. J., 311: 846-847.
24. Meybodi, M.A., M. Afkhami-Ardekani and M. Rashidi, 2008. Prevalence of abnormal serum alanine aminotransferase levels in type 2 diabetic patients in Iran. Pak. J. Biol. Sci., 11: 2274-2277.
25. Mohamadnejad, M., A. Pourshams, R. Malekzadeh, A. Mohamadkhani and A. Rajabiani et al., 2003. Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors. World J. Gastroenterol., 9: 2322-2324.
26. Morisco, F., T. Stroffolini, A. Mele, G. Taliani and A. Smedile et al., 2010. Etiology of and risk factors for transient and persistent aminotransferase elevation in a population of virus-free blood donors: A multicentre study. Digestive Liver Dis., 42: 441-445.
27. Mosallanejad, B., R. Avizeh and H.N. Varzi, 2011. Successful treatment of stanozolol induced-hepatotoxicity with silymarin in a bitch. Asian J. Anim. Sci., 5: 213-218.
28. Nasiri, E. and S.J. Hosseinimehr, 2006. The effect of halothane on SGOT and SGPT of operating room personnel. Pak. J. Biol. Sci., 9: 299-301.
29. Oguntibeju, O.O. and O. Banjoko, 2003. A study on the activities of liver enzymes in HIV/AIDS patients. J. Med. Sci., 3: 106-109.
30. Pan, C.Q. and J.X. Zhang, 2005. Natural history and clinical consequences of hepatitis B virus infection. Int. J. Med. Sci., 2: 36-40.
31. Pervez, K., 2000. Effect of combination chemotherapy on hepatitis C virus in hepatic patients. Pak. J. Biol. Sci., 3: 969-970.
32. Pourshams, A., R. Malekzadeh, A. Monavvari, M.R. Akbari and A. Mohamadkhani et al., 2005. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J. Gastroenterol. Hepatol., 20: 229-233.
33. Prakash, M., J.K. Shetty, S. Tripathy, M. Verma, S. Vasudev and P.V. Bhandary, 2008. Serum total Thiol status in alcohol abusers. Asian J. Biochem., 3: 48-51.
34. Prati, D., E. Taioli, A. Zanella, E.D. Torre, S. Butelli and E. Del-Vecchio et al.,. 2002. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann. Internal Med., 137: 1-9.
35. Prati, D., M.L. Shiffman, M. Diago, E. Gane and K.R. Reddy et al., 2006. Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C. J. Hepatol., 44: 679-685.
36. Ruhl, C.E. and J.E. Everhart, 2003. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology, 124: 71-79.
37. Schreiber, G.B., M.P. Busch, S.H. Kleinman and J.J. Korelitz, 1996. The risk of transfusion-transmitted viral infections. The retrovirus epidemiology donor study. N. Eng. J. Med., 334: 1685-1690.
38. Tabassum, F., R. Khurshid and M.W. Akhtar, 2000. Identification of marker protein, in patient with chronic liver disease. Pak. J. Biol. Sci., 3: 1509-1510.
39. Tarrass, F., J.L. Koenig, F. Leroy, L. Mackaya and H. Colomb, 2006. Transfusion-Transmitted Virus (TTV) and renal failure. Nephrol. Ther., 2: 176-182.
40. Umar, R.A., S.W. Hassan, M.J. Ladan, I.K. Matazu and B. Shehu et al., 2008. Adverse hepatic effects associated with administration of antiretroviral drugs (nevirapine, lamivudine and stavudine) to albino rats: Implication for management of patients with HIV/AIDS. Asian J. Biochem., 3: 19-25.
41. Valla, D.C., 2003. Unexplained chronic increase of transaminases actvity. Hepato-Gastro, 10: 257-263.
42. Vassault, A. and H. Fontaine, 2006. Biological markers of alcoholism. Rev. Francophone Lab., 36: 57-63.
43. Vincent-Viry, M., 1990. Alanine Aminotransferase, Aspartate Aminotransferase. In: References in Clinical Biology, Siest, J., J. Henny and S. Schiele (Eds.). Elsevier Publisher, Paris, France, pp: 77-92, 123-138.
44. Zaier, M., M.S. Gallah, B. Houissa, S. Abdeikefi and L. Ghachem et al., 2002. Role of ALT level in preventing post-transfusional hepatitis. Prospective study of 1,180 blood donors in Tunisia. Tunisie Med., 80: 455-457.
45. Zhang, H., S.M. He, J. Sun, C. Wang and Y.F. Jiang et al., 2011. Prevalence and etiology of abnormal liver tests in an adult population in Jilin, China. Int. J. Med. Sci., 8: 254-262.